Targeting pediatric cancer stem cells with oncolytic virotherapy
/in International Publications, Newcastle Disease Virus /von 2012-02-15 / Pediatr. Res. 2012 Apr;71(4 Pt 2):500-10Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses
/in Hyperthermia, International Publications, Ovarian Cancer /von 2012-02-13 / Toxicol. Sci. 2012 May;127(1):139-49Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2012-01-26 / Cancer Immunol. Immunother. 2012 Sep;61(9):1407-13HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-17 / Cancer 2012 Sep;118(17):4354-62Newcastle disease virus LaSota strain kills human pancreatic cancer cells in vitro with high selectivity
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2012-01-10 / JOP 2012 Jan;13(1):45-53Immunotherapy for metastatic colorectal cancer: present status and new options
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2012-01-03 / Scand. J. Gastroenterol. 2012 Mar;47(3):315-24Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-01-01 / Cell Biochem. Biophys. 2012 Jan;62(1):91-9Effector CD8+ T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia
/in Hyperthermia, International Publications /von 2012-01-01 / Int J Hyperthermia 2012;28(1):9-18Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress
/in Hyperthermia, International Publications /von 2012-01-01 / Apoptosis 2012 Jan;17(1):102-12
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de